Skip to Main Content

Author Details

Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
2008
61
26
PMIDPaper TitleJournal TitlePublished Year
37267699Genomics driven precision oncology in advanced biliary tract cancer improves survival.Neoplasia2023
37275084A Randomized Study to Evaluate Efficacy and Toxicity Profile of Paclitaxel-carboplatin as Neo-adjuvant Chemotherapy in Locally Advanced Supraglottic and Hypopharyngeal Primaries.Indian J Otolaryngol Head Neck Surg2023
37267699Genomics driven precision oncology in advanced biliary tract cancer improves survival.Neoplasia2023
37425208A case of dermatofibrosarcoma protuberans of the scalp treated with surface mould brachytherapy.J Contemp Brachytherapy2023
37425208A case of dermatofibrosarcoma protuberans of the scalp treated with surface mould brachytherapy.J Contemp Brachytherapy2023
37275084A Randomized Study to Evaluate Efficacy and Toxicity Profile of Paclitaxel-carboplatin as Neo-adjuvant Chemotherapy in Locally Advanced Supraglottic and Hypopharyngeal Primaries.Indian J Otolaryngol Head Neck Surg2023
35945154A GPU-accelerated compute framework for pathogen genomic variant identification to aid genomic epidemiology of infectious disease: a malaria case study.Brief Bioinform2022
35945154A GPU-accelerated compute framework for pathogen genomic variant identification to aid genomic epidemiology of infectious disease: a malaria case study.Brief Bioinform2022
36054329de novo variant calling identifies cancer mutation signatures in the 1000 Genomes Project.Hum Mutat2022
36054329de novo variant calling identifies cancer mutation signatures in the 1000 Genomes Project.Hum Mutat2022
33417831Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.Cancer Cell2021
33630025Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.JAMA Oncol2021
34099557Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.Proc Natl Acad Sci U S A2021
33762485Advances in radiotherapy in 2020: Hypofractionation - less is more in times of COVID-19.Indian J Cancer2021
33417831Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.Cancer Cell2021
33630025Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.JAMA Oncol2021
33762485Advances in radiotherapy in 2020: Hypofractionation - less is more in times of COVID-19.Indian J Cancer2021
34099557Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.Proc Natl Acad Sci U S A2021
32299640Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.Eur Urol2020
31728962Case Study: Systematic Detection and Prioritization of Gene Fusions in Cancer by RNA-Seq: A DIY Toolkit.Methods Mol Biol2020
32299640Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.Eur Urol2020
32114502Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer.J Immunother Cancer2020
32154134Mutations predictive of hyperactive Ras signaling correlate with inferior survival across high-risk pediatric acute leukemia.Transl Pediatr2020
31983310Somatic <i>CACNA1H</i> Mutation As a Cause of Aldosterone-Producing Adenoma.Hypertension2020
33033789Identification of Somatic Mutations in <i>CLCN2</i> in Aldosterone-Producing Adenomas.J Endocr Soc2020
32628669GSMN-ML- a genome scale metabolic network reconstruction of the obligate human pathogen Mycobacterium leprae.PLoS Negl Trop Dis2020
32499547An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development.Nat Commun2020
31728962Case Study: Systematic Detection and Prioritization of Gene Fusions in Cancer by RNA-Seq: A DIY Toolkit.Methods Mol Biol2020
31983310Somatic <i>CACNA1H</i> Mutation As a Cause of Aldosterone-Producing Adenoma.Hypertension2020
33033789Identification of Somatic Mutations in <i>CLCN2</i> in Aldosterone-Producing Adenomas.J Endocr Soc2020
32628669GSMN-ML- a genome scale metabolic network reconstruction of the obligate human pathogen Mycobacterium leprae.PLoS Negl Trop Dis2020
32154134Mutations predictive of hyperactive Ras signaling correlate with inferior survival across high-risk pediatric acute leukemia.Transl Pediatr2020
32114502Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer.J Immunother Cancer2020
32499547An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development.Nat Commun2020
30709876Refractory and metastatic infantile fibrosarcoma harboring <i>LMNA-NTRK1</i> fusion shows complete and durable response to crizotinib.Cold Spring Harb Mol Case Stud2019
31741959Tolerance of Chemoradiation in Advanced Head and Neck Cancers: Comparison Between Inpatients and Outpatients.Indian J Otolaryngol Head Neck Surg2019
31243372Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.Nature2019
30709876Refractory and metastatic infantile fibrosarcoma harboring <i>LMNA-NTRK1</i> fusion shows complete and durable response to crizotinib.Cold Spring Harb Mol Case Stud2019
31741959Tolerance of Chemoradiation in Advanced Head and Neck Cancers: Comparison Between Inpatients and Outpatients.Indian J Otolaryngol Head Neck Surg2019
31243372Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.Nature2019
29302777Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas.Acta Neuropathol2018
32832831Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program.JCO Precis Oncol2018
32832832Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors.JCO Precis Oncol2018
30049282Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.Acta Neuropathol Commun2018
30285995VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.Am J Surg Pathol2018
29906450Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.Cell2018
29941307Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma.Eur Urol2018
29572239Identification of novel <i>MECOM</i> gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review.Cold Spring Harb Mol Case Stud2018
29302777Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas.Acta Neuropathol2018
29337305Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.J Clin Invest2018
  • 1 - 50 of 122

Recommended Authors

Samsung Genome Institute, Samsung Medical Center
Career Start Year 2013
Number of shared co-authors 1
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 0
Oregon State University
Career Start Year 2011
Number of shared co-authors 0
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 2
Howard Hughes Medical Institute
Career Start Year 2009
Number of shared co-authors 2
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 0
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 8
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 4
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 2
University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 7
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 2
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 1
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 1
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 4
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 13
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 7
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 8
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 4
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 1
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 11
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 11
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 11
Northwestern University Feinberg School of Medicine
Career Start Year 1998
Number of shared co-authors 0
University of Chicago
Career Start Year 1998
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 5
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 3
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 13
Queen's University
Career Start Year 1982
Number of shared co-authors 7

Collaborators

University of Michigan Medical School.
Co-authored papers 32
Michigan Center for Translational Pathology.
Co-authored papers 23
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 19
University of Michigan Medical School ann arbor
Co-authored papers 19
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 16
Co-authored papers 14
Co-authored papers 11
Co-authored papers 10
Co-authored papers 10
Michigan Center for Translational Pathology.
Co-authored papers 10
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 10
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 9
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 7
University of Michigan Rogel Cancer Center.
Co-authored papers 5
UCSF Medical Center-Mount Zion
Co-authored papers 5
University of Michigan ann arbor
Co-authored papers 4
Co-authored papers 4
Ontario Institute for Cancer Research
Co-authored papers 4
Vattikuti Urology Institute
Co-authored papers 4
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 4
University of Michigan-Ann Arbor
Co-authored papers 4
Co-authored papers 4
Rogel Comprehensive Cancer Center, University of Michigan ann arbor
Co-authored papers 4
Karmanos Cancer Center, Wayne State University
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Northwestern University
Co-authored papers 3
The Institute for Cancer Research
Co-authored papers 3
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 3
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 3
University of Michigan ann arbor
Co-authored papers 3